Inner Mongolia Furui Medical Science Co., Ltd. (300049)
Market Open
10 Aug, 06:57
XSHE XSHE Primary ¥
42. 47
-2.33
-5.2009%
¥
17.85B Market Cap
- P/E Ratio
0.8% Div Yield
12.63M Volume
- Eps
¥ 44.8
Previous Close Want to track 300049 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
300049 trading today lower at ¥42.47, a decrease of -5.2009% from yesterday's close, completing a monthly increase of 9.6% or ¥3.72. Over the past 12 months, 300049 stock lost -39.3286%.
300049 pays dividends to its shareholders, with the most recent payment made on Jul 06, 2026. The next estimated payment will be in 1 month ago on Jul 06, 2026 for a total of ¥0.15.
The last earnings report, released on May 21, 2025, exceeded the consensus estimates by 0.1089%. On average, the company has surpassed earnings expectations by 0.1114%, based on the last three reports.
Inner Mongolia Furui Medical Science Co., Ltd. has completed 3 stock splits, with the recent split occurring on Jul 06, 2015.
The company's stock is traded on one exchange.
300049 Chart
People also search for
Inner Mongolia Furui Medical Science Co., Ltd. (300049) FAQ
What is the stock price today?
The current price is ¥42.47.
On which exchange is it traded?
Inner Mongolia Furui Medical Science Co., Ltd. is listed on XSHE.
What is its stock symbol?
The ticker symbol is 300049.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 0.8%.
What is its market cap?
As of today, the market cap is 17.85B.
Has Inner Mongolia Furui Medical Science Co., Ltd. ever had a stock split?
Inner Mongolia Furui Medical Science Co., Ltd. had 3 splits and the recent split was on Jul 06, 2015.
Inner Mongolia Furui Medical Science Co., Ltd. Profile
| Biotechnology Industry | Healthcare Sector | Mr. Guanyi Wang CEO | XSHE Exchange | CNE100000KG1 ISIN |
| CN Country | 867 Employees | 6 Jul 2026 Last Dividend | 4 May 2011 Last Split | 20 Jan 2010 IPO Date |
Overview
Inner Mongolia Furui Medical Science Co., Ltd., founded in 1998 and based in Beijing, China, operates in the pharmaceutical industry both domestically and internationally. The company has evolved its offerings and structure over the years, initially known as Inner Mongolia FuRui Pharmaceutical Limited Liability Company. It focuses on two primary business segments: pharmaceutical production and sales, and diagnostic equipment research and development (R&D), production, and sales. Through its diversified product portfolio and commitment to health management services, Inner Mongolia Furui Medical Science Co.,Ltd. aims to contribute significantly to the healthcare sector by providing innovative solutions for disease management and diagnostic procedures.
Products and Services
- Fufang Biejiaruangan tablets and shell fat capsules: These are pharmaceutical products produced and sold by the company under its pharmaceutical production and sales segment. The Fufang Biejiaruangan tablets are among the company's proprietary traditional Chinese medicine offerings, designed to offer therapeutic benefits for specific health conditions. Similarly, the shell fat capsules are aimed at addressing various health issues, leveraging traditional medicinal knowledge combined with modern pharmaceutical processes.
- FibroScan series of liver fibrosis diagnostic instruments: Developed, produced, and sold by the company's diagnostic equipment R&D, production, and sales segment, these instruments represent the latest in diagnostic technology for liver fibrosis. The FibroScan series is pivotal in non-invasively assessing the health of the liver, thus playing a crucial role in the early diagnosis and management of liver diseases. By innovating in the field of diagnostic equipment, Inner Mongolia Furui Medical Science Co., Ltd. enables healthcare providers to offer better care through accurate and efficient diagnostic solutions.
- Health Management Services: Beyond pharmaceuticals and diagnostic devices, the company extends its contribution to healthcare through health management services. These services are designed to offer support and management solutions for individuals looking to maintain or improve their health, thus representing a holistic approach towards healthcare by integrating preventive and curative aspects.
- Prescription Drugs: As part of its core offerings in the pharmaceutical sector, Inner Mongolia Furui Medical Science Co., Ltd. provides a range of prescription drugs aimed at treating various diseases. The company's emphasis on research and development ensures that its portfolio of prescription medications meets high standards of efficacy and safety, addressing the needs of a diverse patient population.
Contact Information
Address: Building 2, Kunsha Center, Beijing, China, 100027
Phone: 86 10 8468 2800
Website: https://www.fu-rui.com
